Profile and factors determining outcome in a cohort of cystic fibrosis patients seen at the Aga Khan University Hospital, Karachi, Pakistan.

Cystic fibrosis is the most common potentially lethal autosomal recessive, genetic disease associated with pulmonary and pancreatic insufficiency. It is caused by variations in the CFTR (cystic fibrosis transmembrane regulator) gene. The most common mutation in the CFTR gene designated DeltaF508, is found in only 33 per cent of CF patients in Pakistan. The variability in presentation and clinical severity of disease may be a function of genotypic-phenotypic factors. Our aim was to attempt to define the disease in this region and to lay the ground work for future mutational analysis. This study was a retrospective chart review was conducted to identify cystic fibrosis patients seen at the Aga Khan University Hospital over a 10-year period. Our study identified 56 patients diagnosed by a pilocarpine iontophoresis sweat test. A chart review was then done to look at the various clinical profiles. 58.3 per cent of our patients presented in the first 6 months of life supporting the hypothesis that CF may be a severe disease in Asians with an earlier age of presentation. Most of the patients (80.6 per cent) presented with pulmonary problems while 83.9 per cent had failure to thrive. The most frequently isolated pathogen was Pseudomonas aeruginosa in 87.5 per cent of the patients tested. 70 per cent of the patients died in the first year of life. The clinical parameters studied suggest a severe form of CF in Pakistani patients and provides a foundation for future studies to define genotype/phenotype correlations of the specific mutations involved in Pakistani CF patients.

[1]  G. Alexander,et al.  Hepatocellular carcinoma in association with cirrhosis in a patient with cystic fibrosis. , 2004, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

[2]  R. Lodha,et al.  Clinical profile and frequency of delta f508 mutation in Indian children with cystic fibrosis. , 2003, Indian pediatrics.

[3]  S. Emerson,et al.  Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study , 2003, The Lancet.

[4]  A. Morabito,et al.  Liver disease in cystic fibrosis: A prospective study on incidence, risk factors, and outcome , 2002, Hepatology.

[5]  R. Prasad,et al.  Cystic fibrosis in north Indian children , 2002, Indian journal of pediatrics.

[6]  R. Sokol,et al.  Cholangiocyte Biology and Cystic Fibrosis Liver Disease , 2001, Seminars in liver disease.

[7]  Z. Bhutta,et al.  Genetic analysis of cystic fibrosis in Pakistan: a preliminary report. , 2000, JPMA. The Journal of the Pakistan Medical Association.

[8]  B. Strandvik,et al.  Natural history of liver disease in cystic fibrosis , 1999, Hepatology.

[9]  F. Al-Mahroos,et al.  Cystic fibrosis in bahrain incidence, phenotype, and outcome. , 1998, Journal of tropical pediatrics.

[10]  S. Kabra,et al.  Delta F 508 molecular mutation in Indian children with cystic fibrosis. , 1996, The Indian journal of medical research.

[11]  P. Farrell,et al.  Sweat chloride concentrations in infants homozygous or heterozygous for F508 cystic fibrosis. , 1996, Pediatrics.

[12]  S. Kabra,et al.  Cystic fibrosis-an Indian perspective on recent advances in diagnosis and management , 1996, Indian journal of pediatrics.

[13]  S. Higgins,et al.  Cystic fibrosis in children from ethnic minorities in the West Midlands. , 1994, Respiratory medicine.

[14]  S. Bhattacharya,et al.  Absence of cystic fibrosis mutations in a large Asian population sample and occurrence of a homozygous S549N mutation in an inbred Pakistani family. , 1993, Journal of medical genetics.

[15]  J. Littlewood,et al.  Cystic fibrosis in Asians. , 1993, Archives of disease in childhood.

[16]  M. Tanner,et al.  Prevalence of liver disease in cystic fibrosis. , 1991, Archives of disease in childhood.

[17]  M. Welsh,et al.  Generation of cAMP-activated chloride currents by expression of CFTR. , 1991, Science.

[18]  A. Markham,et al.  ΔF508 testing of the DNA bank of the Royal Manchester Children's Hospital , 1990, Human Genetics.

[19]  R. Wilmott,et al.  Cystic fibrosis survival rates. The influences of allergy and Pseudomonas aeruginosa. , 1985, American journal of diseases of children.

[20]  R. Grand,et al.  Gastrointestinal manifestations of cystic fibrosis: a review. , 1981, Gastroenterology.

[21]  D. Rushton,et al.  Cystic fibrosis in 3 Pakistani children. , 1974, Archives of disease in childhood.

[22]  E. Girodon,et al.  Identification of cystic fibrosis mutations in the United Arab Emirates , 1998 .

[23]  M. Schwarz,et al.  Detection of five novel mutations of the cystic fibrosis transmembrane regulator (CFTR) gene in Pakistani patients with cystic fibrosis: Y569D, Q98X, 296+12(T>C), 1161delC and 621+2(T>C) , 1998, Human mutation.

[24]  P. Pignatti,et al.  Genotype-phenotype correlations in Cystic Fibrosis. , 1997 .

[25]  S. Fitzsimmons,et al.  The changing epidemiology of cystic fibrosis. , 1993, The Journal of pediatrics.

[26]  C. Boeck Correlation between genotype and phenotype in patients with cystic fibrosis , 1993 .